Today, House Republicans unveiled H.R. 19, the Lower Costs, More Cures Act, a bipartisan plan to reduce prescription drug prices. Representative Mike Kelly (R-Pa.), an original co-sponsor of the legislation, issued the following statement following its introduction:
Americans are facing a prescription drug affordability crisis. People from all walks of life are struggling to buy the medicines they need to live happy and healthy lives. The Lower Costs, More Cures Act would require more transparency in drug pricing, lower out of pocket costs to patients, and protect and foster medical innovation. If Democrats are serious about lowering the cost of prescription drugs, they will join us to deliver this bipartisan solution our country desperately needs instead of passing partisan government price fixing schemes.